Enhancing Intracellular Uptake of Ivermectin through Liposomal Encapsulation
Open Access
- 2 May 2025
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (5) , 1-11
Abstract
Ivermectin (IVM), an antiparasitic drug approved by the Food and Drug Administration (FDA), is widely used to treat several neglected tropical diseases, including onchocerciasis, helminthiases, and scabies. Additionally, IVM has shown potential as a potent inhibitor of certain RNA viruses, such as SARS-CoV-2. However, IVM is highly hydrophobic, essentially insoluble in water, which limits its bioavailability and therapeutic effectiveness. The use of liposomes as drug carriers offers several advantages, including enhanced solubility for lipophilic drugs, passive targeting of immune system cells, sustained release, and improved tissue penetration. To address the limitations of IVM, including its poor solubility and bioavailability, liposomal formulations were developed using a combination of soyphosphatidylcholine (SPC), dioleylphosphatidylcholine (DOPC), cholesterol (Ch), and diethylphosphate (DCP) in two distinct molar ratios (1.85:1:0.15 and 7:2:1) via the ethanol injection method. The physicochemical properties of the placebo and IVM-loaded liposomes were extensively characterized in our earlier study, including the particle size, polydispersity index, and zeta potential. The present work adds a deeper level of investigation into how to effect cellular uptake and cytotoxicity in vitro of both free IVM and IVM-loaded liposomes in Vero E6 cells. The half-maximal cytotoxic concentrations (CC50) for free IVM and IVM-loaded liposomes were 10 μM and > 110 μM, respectively and the cellular uptake of IVM-loaded liposomes ranged from 13 to 60%, whereas free IVM showed a significantly lower uptake of only 2%. These results demonstrate that liposomal encapsulation effectively enhances IVM’s cellular uptake while reducing its cytotoxicity, thus offering a promising strategy for improving the effectiveness of IVM. Graphical AbstractKeywords
Funding Information
- Social Science University of Ankara
This publication has 62 references indexed in Scilit:
- Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier systemArchiv der Pharmazie, 2024
- A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular VesiclesAdvanced Healthcare Materials, 2023
- Ethanol Injection Method for Liposome Preparation2023
- Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activationEnvironmental Toxicology, 2021
- Preformulation study of ivermectin raw materialJournal of Thermal Analysis and Calorimetry, 2014
- Microfluidic Preparation of Liposomes to Determine Particle Size Influence on Cellular Uptake MechanismsPharmaceutical Research, 2013
- Zeta Potential Measurement2010
- New Drug Delivery Nanosystem Combining Liposomal and Dendrimeric Technology (Liposomal Locked-In Dendrimers) for Cancer TherapyJournal of Pharmaceutical Sciences, 2010
- Drug delivery systems: Advanced technologies potentially applicable in personalized treatmentsEPMA Journal, 2010
- Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administrationParasitology Research, 2005